financetom
Business
financetom
/
Business
/
Intra-Cellular Therapies CFO Hineline Retiring, Promotes Halstead to President
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Intra-Cellular Therapies CFO Hineline Retiring, Promotes Halstead to President
Mar 19, 2024 8:38 AM

11:12 AM EDT, 03/19/2024 (MT Newswires) -- Intra-Cellular Therapies ( ITCI ) said Tuesday that Chief Financial Officer Larry Hineline will be retiring after more than 20 years of service and the company has started an external search for a new CFO.

Additionally, the biopharmaceutical company said it has promoted Michael Halstead to the position of president. Halstead is currently an executive vice president and general counsel.

Price: 65.34, Change: -0.03, Percent Change: -0.05

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Market Chatter: Procter & Gamble to Disclose Audit Details on Wood Pulp Suppliers
Market Chatter: Procter & Gamble to Disclose Audit Details on Wood Pulp Suppliers
Dec 16, 2024
08:04 AM EST, 12/16/2024 (MT Newswires) -- Procter & Gamble ( PG ) promised a group of shareholders it would disclose more details on its audit practices for wood pulp suppliers, Reuters reported Monday, citing the investors. Certain shareholders have been pushing the company to source forest products more sustainably, the report said. The investors and P&G are next expected...
Phillips 66 to Sell Gulf Coast Express Pipeline Stake for $865 Million
Phillips 66 to Sell Gulf Coast Express Pipeline Stake for $865 Million
Dec 16, 2024
08:09 AM EST, 12/16/2024 (MT Newswires) -- Phillips 66 (PSX) said Monday it agreed to sell DCP GCX Pipeline, which holds a 25% non-operated stake in the Gulf Coast Express Pipeline, to an ArcLight Capital Partners affiliate for pre-tax proceeds of $865 million in cash, subject to adjustments. The energy provider said the sale price represents a 10.6x multiple of...
Soligenix Begins Patient Enrollment for Phase 3 Study of Drug Candidate for Cutaneous T-Cell Lymphoma
Soligenix Begins Patient Enrollment for Phase 3 Study of Drug Candidate for Cutaneous T-Cell Lymphoma
Dec 16, 2024
08:05 AM EST, 12/16/2024 (MT Newswires) -- Soligenix ( SNGX ) said Monday it has begun patient enrollment for its phase 3 study of its experimental therapy, HyBryte, to treat cutaneous T-cell lymphoma or CTCL. The company said the study builds on previous phase 3 results and additional supportive research. ...
Whitecap Resources Says Q4, Full-Year Production to Beat Guidance
Whitecap Resources Says Q4, Full-Year Production to Beat Guidance
Dec 16, 2024
08:05 AM EST, 12/16/2024 (MT Newswires) -- Whitecap Resources ( SPGYF ) on Monday said fourth-quarter production is now forecast to average 175,500 boe/d (65% liquids), above its previous guidance of 170,000 boe/d. Full-year production is expected to average 174,000 boe/d, 5% above Whitecap's original guidance of 162,000 - 168,000 boe/d. The company's annual production per share growth in 2024...
Copyright 2023-2026 - www.financetom.com All Rights Reserved